极早产儿呼吸窘迫综合征肺复张后表面活性物质给药(IN-REC-SUR-E)随机对照试验
在意大利35个三级新生儿重症监护室开展的随机非盲对照试验,纳入218例24+0至27+6周、生后24小时内CPAP失败的极早产儿,比较IN-REC-SUR-E与IN-SUR-E策略。
要点
- 极早产儿CPAP失败后,表面活性物质给药前肺复张可减少72小时内机械通气需求。
- 肺复张未增加院内死亡、气胸或3级及以上脑室内出血风险。
核心结论
- 表面活性物质给药前肺复张可提高极早产儿表面活性物质疗效,减少生后72小时内机械通气需求,且不增加不良新生儿结局风险。
研究设计与样本
- 随机、非盲、对照试验,在意大利35个三级新生儿重症监护室开展,纳入218例24+0至27+6周、生后24小时内CPAP失败的极早产儿,1:1随机分组。
主要发现
- 院内死亡IN-REC-SUR-E组19/101(19%)vs IN-SUR-E组37/111(33%)。
- 气胸4/101(4%)vs 7/111(6%);3级及以上脑室内出血12/101(12%)vs 17/111(15%)。
关键数值与推荐
- 纳入标准:胎龄24+0至27+6周、生后24小时内达到CPAP失败标准的极早产儿。
- 主要结局:生后72小时内需要机械通气。
- 分析采用意向治疗和符合方案人群,对数二项回归模型校正分层因素估计调整RR。
临床怎么用
- 对CPAP失败的极早产儿,在表面活性物质给药前可考虑应用肺复张操作,随后快速拔管,以减少早期机械通气需求。
- 该策略未增加院内死亡、气胸或严重脑室内出血风险,可能有助于实施无创呼吸支持策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The importance of lung recruitment before surfactant administration has been shown in animal studies. Well designed trials in preterm infants are absent. We aimed to examine whether the application of a recruitment manoeuvre just before surfactant administration, followed by rapid extubation (intubate-recruit-surfactant-extubate [IN-REC-SUR-E]), decreased the need for mechanical ventilation during the first 72 h of life compared with no recruitment manoeuvre (ie, intubate-surfactant-extubate [IN-SUR-E]). METHODS: We did a randomised, unblinded, controlled trial in 35 tertiary neonatal intensive care units in Italy. Spontaneously breathing extremely preterm neonates (24 + 0 to 27 + 6 weeks' gestation) reaching failure criteria for continuous positive airway pressure within the first 24 h of life were randomly assigned (1:1) with a minimisation algorithm to IN-REC-SUR-E or IN-SUR-E using an interactive web-based electronic system, stratified by clinical site and gestational age. The primary outcome was the need for mechanical ventilation in the first 72 h of life. Analyses were done in intention-to-treat and per-protocol populations, with a log-binomial regression model correcting for stratification factors to estimate adjusted relative risk (RR). This study is registered with ClinicalTrials.gov, NCT02482766. FINDINGS: Of 556 infants assessed for eligibility, 218 infants were recruited from Nov 12, 2015, to Sept 23, 2018, and included in the intention-to-treat analysis. The requirement for mechanical ventilation during the first 72 h of life was reduced in the IN-REC-SUR-E group (43 [40%] of 107) compared with the IN-SUR-E group (60 [54%] of 111; adjusted RR 0·75, 95% CI 0·57-0·98; p=0·037), with a number needed to treat of 7·2 (95% CI 3·7-135·0). The addition of the recruitment manoeuvre did not adversely affect the safety outcomes of in-hospital mortality (19 [19%] of 101 in the IN-REC-SUR-E group vs 37 [33%] of 111 in the IN-SUR-E group), pneumothorax (four [4%] of 101 vs seven [6%] of 111), or grade 3 or worse intraventricular haemorrhage (12 [12%] of 101 vs 17 [15%] of 111). INTERPRETATION: A lung recruitment manoeuvre just before surfactant administration improved the efficacy of surfactant treatment in extremely preterm neonates compared with the standard IN-SUR-E technique, without increasing the risk of adverse neonatal outcomes. The reduced need for mechanical ventilation during the first 72 h of life might facilitate implementation of a non-invasive respiratory support strategy. FUNDING: None.
引用
- Vento G, Ventura ML, Pastorino R, et al. Lung recruitment before surfactant administration in extremely preterm neonates with respiratory distress syndrome (IN-REC-SUR-E): a randomised, unblinded, controlled trial. Lancet Respir Med. 2020. PMID: 32687801. doi:10.1016/S2213-2600(20)30179-X
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。